The U.S. Pharma Premium: Who’s Really Paying the Price?
June 30, 2025
For decades, the United States has shouldered a disproportionate share of global pharmaceutical costs, accounting for 70% of global biopharma profits and over 80% of new drug launches. While this has helped drive significant medical innovation and supported the majority of global drug launches, it has also resulted in higher out-of-pocket costs for American patients.
All Aboard: Executive Actions to Ensure Maritime Cyber Resilience Amid Deals and Digitization
June 30, 2025
As the maritime world sails deeper into digital waters, cyber threats are no longer just an IT issue — they’re a boardroom priority. Discover the critical actions executives must take to safeguard resilience, reputation, and deal value in a high-stakes, high-risk seascape.
ALVAREZ & MARSAL RELEASES SAUDI ARABIA BANKING PULSE FOR Q1 2025
June 30, 2025
The KSA Banking Pulse, analyzes the performance of KSA's 10 largest listed banks for q1 2025, and highlights a strong start to the year marked by improved profitability, cost discipline, and accelerating corporate credit growth.
AI, Cross‑Border Growth, Tier 2/3 Expansion & Omnichannel Transforming India’s Startup: Meta-Alvarez & Marsal India Report
June 27, 2025
Our newest report, commissioned by Meta, extracts insights from over 100 high-growth Indian start-ups and highlights six crucial factors shaping the next stage of enterprise expansion.
